Key Insights

Highlights

Success Rate

95% trial completion (above average)

Published Results

14 trials with published results (9%)

Research Maturity

105 completed trials (67% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

3.2%

5 terminated out of 156 trials

Success Rate

95.5%

+8.9% vs benchmark

Late-Stage Pipeline

22%

34 trials in Phase 3/4

Results Transparency

13%

14 of 105 completed with results

Key Signals

14 with results95% success

Data Visualizations

Phase Distribution

112Total
Not Applicable (68)
Early P 1 (1)
P 1 (2)
P 2 (7)
P 3 (11)
P 4 (23)

Trial Status

Completed105
Unknown30
Recruiting7
Withdrawn5
Terminated5
Enrolling By Invitation2

Trial Success Rate

95.5%

Benchmark: 86.5%

Based on 105 completed trials

Clinical Trials (156)

Showing 20 of 20 trials
NCT04206228Phase 2Completed

Intravenous Iron Supplement for Iron Deficiency in Patients With Severe Aortic Stenosis

NCT07442305Not Yet Recruiting

Assessing Dietary Intake of Selected Food Components Using Short Questionnaires

NCT04945707Phase 4RecruitingPrimary

Impact of Intravenous Iron Repletion On Mechanisms of Exercise InTolerance in HFpEF (IRONMET-HFpEF)

NCT04810546Not ApplicableCompletedPrimary

Feasibility or Oral Lactoferrin to Prevent Iron Deficiency Anemia in Obese Pregnancy

NCT05340465Phase 2Recruiting

Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants

NCT05309499Not ApplicableCompleted

An Open Study on the Efficacy of Iron Therapy Using iv Iron Relative to Oral Iron for Increasing LV Systolic Function

NCT05126901Phase 3Completed

Evaluate the Safety and Efficacy of Ferric Maltol Oral Suspension vs. Ferrous Sulfate Oral Liquid in Children and Adolescents Aged 2 to 17 Years With Iron-deficiency Anaemia, With a Single Arm Study in Infants Aged 1 Month to Less Than 2 Years

NCT04144790Completed

Impact of Iron Supplementation Treatment on Brain Iron Concentrations

NCT06270498Phase 4Recruiting

Effect of Oral sucRosomIal Iron on exerciSE Capacity and Quality of Life in Patients With Heart Failure

NCT04250298Not ApplicableCompletedPrimary

Sucrosom5al Iron Supplementation in Blood Donors

NCT04744181Completed

Patient Blood Management In CARdiac sUrgical patientS

NCT03978260Completed

Preoperative Anaemia prevaLence In surgiCal patiEnts

NCT06115122Recruiting

PEPPI Study: Identification of Women at Risk for Placental Dysfunction

NCT07083492Recruiting

Non-invasive Detection of Iron Deficiency in Obstetrics

NCT03897673Not ApplicableCompleted

Optimizing Benefits While Reducing Risks of Iron in Malaria-endemic Areas

NCT06285799Phase 3CompletedPrimary

Safety and Effectiveness of Iron Hydroxide Adipate Tartrate (IHAT) in Iron Deficient Premenopausal Women

NCT05816265Phase 4Enrolling By Invitation

Effects of IV Iron Replacement on Exercise Capacity in Individuals With Heart Failure

NCT05407987Phase 3Recruiting

Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery)

NCT04705662Not ApplicableCompleted

GI Effects of Iron in Healthy Volunteers

NCT05514951Not ApplicableCompletedPrimary

Study of the Prevalence of Iron Deficiency in Elderly Patient in Hospital Environment

Scroll to load more

Research Network

Activity Timeline